| (EUR) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 118.10M | — |
| Operating expense | — | — |
| Net income | -531.90M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 22UA.DE returned +6.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +25.0% |
| 1 year | +6.2% |
| 5 years | -65.5% |
| All-time high | €299.20 (Nov 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 22UA.DE would be worth today ›No. BioNTech SE has not paid a dividend in the past 12 months.
BioNTech SE is part of the Healthcare sector.
BioNTech SE has a market cap of 24.13B EUR, based on the latest quote.
BioNTech SE is scheduled to report earnings on Nov 3, 2026.
